S2DV: converting SMILES to a drug vector for predicting the activity of anti-HBV small molecules

In the past few decades, chronic hepatitis B caused by hepatitis B virus (HBV) has been one of the most serious diseases to human health. The development of innovative systems is essential for preventing the complex pathogenesis of hepatitis B and reducing side effects caused by drugs. HBV inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Jinsong, Gong, Qineng, Yin, Zeyu, Pan, Wenjie, Pandiyan, Sanjeevi, Wang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Problem Solving Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921627/
https://www.ncbi.nlm.nih.gov/pubmed/35062019
http://dx.doi.org/10.1093/bib/bbab593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921627/
https://www.ncbi.nlm.nih.gov/pubmed/35062019
http://dx.doi.org/10.1093/bib/bbab593

Ejemplares similares